For following the competition: what moved in each program, several studies read as one move.
- sanritatug
- Anti-LILRB4/MMAE ADC SG2918
- SG1827
- + 1 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Hangzhou Sumgen Biotech to watchlistEvery Monday by email · turn it off any timePro · free during the beta